Literature DB >> 5937060

The renal lesion associated with hemoglobinemia. I. Its production and functional evolution in the rat.

J R Jaenike.   

Abstract

A method is presented for the production of a reproducible and reversible renal lesion in the rat by the intravenous injection of a relatively small amount of homologous hemoglobin (40 mg/100 g body weight). Production of the lesion is dependent on prior water deprivation and its severity is related to the degree of dehydration. Ether anesthesia, at the time of hemoglobin injection, predisposes to a severe and reproducible functional defect in the dehydrated rat. In contrast, injection of hemoglobin during pentobarbital anesthesia results in a significant lesion only sporadically. The functional evolution of the lesion has been characterized by inulin clearance measurements. Functional impairment occurs abruptly, within 1 hr after hemoglobin injection, and persists unchanged over the ensuing several hours. Some increase in inulin clearance rate is usually observed at 24 hr after injection, but severe functional impairment persists. Between 24 and 72 hr, a considerable increase in inulin clearance rate occurs, so that only moderate restriction of excretory function is present at the latter time. A further moderate increase in inulin clearance rate is apparent at 7 days after hemoglobin injection, but some reduction in function. persisted in all rats studied at this time. Hemoglobinuria is slight or inapparent in animals manifesting the most marked depression of excretory function, indicating that a severe renal lesion may exist in the absence of visible urinary pigment. Hemoglobinemia is evanescent at the dosage used in this study. These observations suggest that clinical acute renal failure secondary to hemoglobinemia may readily go unrecognized and that this may be a more frequent association than is now appreciated.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5937060      PMCID: PMC2138157          DOI: 10.1084/jem.123.3.523

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Studies of the acute renal effects of hemolyzed red blood cells in dogs including estimations of renal blood flow with krypton.

Authors:  M GOLDBERG
Journal:  J Clin Invest       Date:  1962-12       Impact factor: 14.808

2.  Circulating adrenaline and noradrenaline during diethyl ether anaesthesia in man.

Authors:  H L PRICE
Journal:  Clin Sci       Date:  1957-05       Impact factor: 6.124

3.  The renal clearance of alkali-stable inulin.

Authors:  M WALSER; D G DAVIDSON; J ORLOFF
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

4.  An instrument and method for rapid, dependable determination of freezing point depression.

Authors:  R L BOWMAN; H V TRANTHAM; P A CAULFIELD
Journal:  J Lab Clin Med       Date:  1954-02

5.  Factors Inducing Renal Shut-down from Lysed Erythrocytes: An Experimental Study.

Authors:  N S Maluf
Journal:  Ann Surg       Date:  1949-07       Impact factor: 12.969

6.  A comparison of the effects of ether and cyclopropane anesthesia on the renal function of man.

Authors:  C H BURNETT; E L BLOOMBERG
Journal:  J Pharmacol Exp Ther       Date:  1949-08       Impact factor: 4.030

7.  THE PATHOGENESIS OF THE RENAL INJURY PRODUCED IN THE DOG BY HEMOGLOBIN OR METHEMOGLOBIN.

Authors:  H E Harrison; H Bunting; N K Ordway; W S Albrink
Journal:  J Exp Med       Date:  1947-09-30       Impact factor: 14.307

8.  The renal lesion associated with hemoglobinemia. II. Its structural characteristics in the rat.

Authors:  J R Jaenike; E E Schneeberger
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

9.  The influence of available fluid on the production of experimental hemoglobinuric nephrosis in rabbits.

Authors:  J J LALICH
Journal:  J Exp Med       Date:  1948-02-01       Impact factor: 14.307

  9 in total
  11 in total

1.  Prevention and early management of acute renal failure.

Authors:  R G Luke; A C Kennedy
Journal:  Postgrad Med J       Date:  1967-04       Impact factor: 2.401

2.  Exercise induced acute renal failure in an athlete.

Authors:  T M Bach; D B Clement
Journal:  Can Fam Physician       Date:  1980-04       Impact factor: 3.275

3.  The renal lesion associated with hemoglobinemia: a study of the pathogenesis of the excretory defect in the rat.

Authors:  J R Jaenike
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

4.  Changes in polymorphonuclear leukocyte elastase concentrations and hemolysis parameters in patients transfused with different blood preparations, and in the blood preparations themselves.

Authors:  Tomoki Nishiyama
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

5.  Renal lesions in ischaemic kidneys infused with haemoglobin: an electron microscopic study.

Authors:  A S Haupt; R Ochs; G E Schubert
Journal:  Urol Res       Date:  1982-02

6.  The early phase of experimental acute renal failure. I. Intratubular pressure and obstruction.

Authors:  J Mason; C Olbricht; T Takabatake; K Thurau
Journal:  Pflugers Arch       Date:  1977-08-29       Impact factor: 3.657

7.  The effects of massive transfusion and haptoglobin therapy on hemolysis in trauma patients.

Authors:  S Gando; I Tedo
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

8.  Significance of hemolysis on extracorporeal life support after cardiac surgery in children.

Authors:  Rasheed Gbadegesin; Shuang Zhao; John Charpie; Patrick D Brophy; William E Smoyer; Jen-Jar Lin
Journal:  Pediatr Nephrol       Date:  2008-11-12       Impact factor: 3.714

9.  Evaluation of a stroma-free hemoglobin solution for use as a plasma expander.

Authors:  S F Rabiner; J R Helbert; H Lopas; L H Friedman
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

10.  The renal lesion associated with hemoglobinemia. II. Its structural characteristics in the rat.

Authors:  J R Jaenike; E E Schneeberger
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.